Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2/3 1

Status

Completed 2

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 2

Sponsor

Conditions

Neoplasms 805Carcinoma, Non-Small-Cell Lung 766Breast Neoplasms 731Neoplasm Metastasis 340Colorectal Neoplasms 339Prostatic Neoplasms 324Multiple Myeloma 309Melanoma 305Recurrence 237Ovarian Neoplasms 236Leukemia, Myeloid, Acute 236Lymphoma, Non-Hodgkin 213Lung Neoplasms 211Carcinoma, Renal Cell 200Lymphoma 189Lymphoma, Follicular 163Pancreatic Neoplasms 157Leukemia, Lymphocytic, Chronic, B-Cell 149Carcinoma, Hepatocellular 140Stomach Neoplasms 137Leukemia 133Head and Neck Neoplasms 128Lymphoma, Large B-Cell, Diffuse 126Parkinson Disease 4, Autosomal Dominant Lewy Body 119Squamous Cell Carcinoma of Head and Neck 110Urinary Bladder Neoplasms 109Carcinoma 101Small Cell Lung Carcinoma 99Triple Negative Breast Neoplasms 97Glioblastoma 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Has results × Dry Eye Syndromes × Clear all
NCT00832130 2011-12-12

Treatment of Meibomian Gland Dysfunction and Evaporative Dry Eye

TearScience, Inc.

Phase NA Completed
139 enrolled 14 charts

Dry Eye Syndromes, Chalazion

NCT01202747 2011-12-06

Evaluation of Screening Methods for Treatment of Meibomian Gland Dysfunction

TearScience, Inc.

Phase 2/3 Completed
50 enrolled 4 charts

Dry Eye Syndromes, Chalazion

Data powered by HemOnc (CC BY 4.0) Colophon âš¡